Literature DB >> 22653016

[Epidemiology of osteoporosis in Japan].

Masayuki Iki1.   

Abstract

The high prevalence and tragic consequences of related fractures make osteoporosis a major burden on modern society. According to population-based epidemiologic studies, the estimated number of people with osteoporosis in Japan is 15 million, and only 20% of them are under treatment. Osteoporosis is a highly undertreated disease. The most recent incidence rates of hip fracture in Japan were 5.1 in 10,000 men and 18.1 in 10,000 women in 2007, and the number of patients are approximately 130 thousands which are 2.8-fold higher than those of the initial survey of 1987, but are still substantially less than rates in Caucasian populations. This increase in incidence rates can be explained by an increase in the elderly population. Data on the prevalence and incidence of vertebral fractures in Japan are vague compared with those of hip fracture. Prevalence rate of vertebral fracture was reported to be comparable to those in Caucasian populations, or even higher, and is approximately 30% in women aged 70s and 40% in those aged 80s. Hip fracture increases the mortality risk by approximately 10% or 20% during one year after the index fracture. Functional level of patients with hip fracture is deteriorated in 60% of them compared with pre-fracture level. Vertebral fracture also increases the risk of mortality even in radiographically determined ones. We currently have 13 million patients with osteoporosis in Japan among whom 130 thousands are suffered from hip fracture every year among whom 20 thousands die and 60 thousands experience functional decline. Effective preventive and therapeutic measures for osteoporosis should be conducted in more efficient ways. A greater role of the new guideline is expected than ever to promote preventive measures against osteoporosis and to increase physician's awareness to this disease.

Entities:  

Mesh:

Year:  2012        PMID: 22653016     DOI: CliCa1206797803

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  14 in total

1.  Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study.

Authors:  Sakae Tanaka; Hideki Mizutani; Eri Tsuruya; Ryoko Fukuda; Kiyoka Kuge; Naoki Okubo
Journal:  J Bone Miner Metab       Date:  2021-01-02       Impact factor: 2.626

2.  Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis.

Authors:  Shoji Seki; Norikazu Hirano; Yoshiharu Kawaguchi; Masato Nakano; Taketoshi Yasuda; Kayo Suzuki; Kenta Watanabe; Hiroto Makino; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Eur Spine J       Date:  2017-01-23       Impact factor: 3.134

3.  Novel adipokines and bone metabolism.

Authors:  Yuan Liu; Cheng-Yuan Song; Shan-Shan Wu; Qiu-Hua Liang; Ling-Qing Yuan; Er-Yuan Liao
Journal:  Int J Endocrinol       Date:  2013-02-04       Impact factor: 3.257

4.  Bone fractures and feeling at risk for osteoporosis among women in Japan: patient characteristics and outcomes in the National Health and Wellness Survey.

Authors:  Masayo Sato; Jeffrey Vietri; Jennifer A Flynn; Saeko Fujiwara
Journal:  Arch Osteoporos       Date:  2014-11-13       Impact factor: 2.617

Review 5.  Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.

Authors:  H Ohta; J Solanki
Journal:  Osteoporos Int       Date:  2014-12-02       Impact factor: 4.507

6.  Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions.

Authors:  Hajime Orimo; Masayo Sato; Shuichi Kimura; Keiko Wada; Xuelu Chen; Shigeto Yoshida; Bruce Crawford
Journal:  Osteoporos Sarcopenia       Date:  2017-11-03

Review 7.  Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.

Authors:  Kazuhiro Imai
Journal:  Clin Interv Aging       Date:  2013-06-07       Impact factor: 4.458

8.  Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management.

Authors:  Hidetaka Wakabayashi; Kunihiro Sakuma
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-09-16       Impact factor: 12.910

9.  Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors.

Authors:  Daisuke Asaoka; Akihito Nagahara; Mariko Hojo; Kenshi Matsumoto; Hiroya Ueyama; Kohei Matsumoto; Kentaro Izumi; Tsutomu Takeda; Hiroyuki Komori; Yoichi Akazawa; Yuji Shimada; Taro Osada; Sumio Watanabe
Journal:  Biomed Rep       Date:  2016-06-30

10.  The preventive effect of Qing Dai on bisphosphonate-induced gastric cellular injuries.

Authors:  Go Yasuda; Hiromu Ito; Hiromi Kurokawa; Masahiko Terasaki; Hideo Suzuki; Yuji Mizokami; Hirofumi Matsui
Journal:  J Clin Biochem Nutr       Date:  2018-11-15       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.